The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study.

MLA

Mercadante S, et al. “The Use of Fentanyl Buccal Tablets as Breakthrough Medication in Patients Receiving Chronic Methadone Therapy: An Open Label Preliminary Study.” Supportive Care in Cancer, vol. 19, no. 3, Mar. 2011, pp. 435–38. EBSCOhost, https://doi.org/10.1007/s00520-010-1015-6.

APA

Mercadante S, Ferrera P, Arcuri E, Mercadante, S., Ferrera, P., & Arcuri, E. (2011). The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study. Supportive Care in Cancer, 19(3), 435–438. https://doi.org/10.1007/s00520-010-1015-6

Chicago

Mercadante S, Ferrera P, Arcuri E, Sebastiano Mercadante, Patrizia Ferrera, and Edoardo Arcuri. 2011. “The Use of Fentanyl Buccal Tablets as Breakthrough Medication in Patients Receiving Chronic Methadone Therapy: An Open Label Preliminary Study.” Supportive Care in Cancer 19 (3): 435–38. doi:10.1007/s00520-010-1015-6.